ESSA Pharma to Present at the JonesHealthcare Seaside Summit

Rhea-AI Summary

ESSA Pharma (NASDAQ: EPIX), a clinical-stage pharmaceutical company aimed at developing innovative prostate cancer treatments, announced its participation in the JonesHealthcare Seaside Summit. The event will take place on July 15, 2024, at 11:00 a.m. PT. The company's President and CEO, David R. Parkinson, will lead the presentation and join a panel discussion titled 'Innovations and Challenges in Prostate Cancer' at 9:00 a.m. PT. The presentation will be webcast live on the Investors/Events & Presentations section of the ESSA Pharma website and will remain archived for 90 days post-event. However, the panel discussion will not be available via webcast.

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, July 8, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will present at the JonesHealthcare Seaside Summit on Monday, July 15, 2024 at 11:00 a.m. PT.

David R. Parkinson, President and Chief Executive Officer, will host the presentation and will also participate in a panel discussion titled "Innovations and Challenges in Prostate Cancer" at 9:00 a.m. PT.

A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days. The panel, "Innovations and Challenges in Prostate Cancer," will not be webcast.

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essaphrma.com, and follow us on X and LinkedIn.

Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
pvirsik@essapharma.com

Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com 

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-joneshealthcare-seaside-summit-302190883.html

SOURCE ESSA Pharma Inc

FAQ

When and where is ESSA Pharma presenting at the JonesHealthcare Seaside Summit?

ESSA Pharma will present at the JonesHealthcare Seaside Summit on July 15, 2024, at 11:00 a.m. PT.

Who will represent ESSA Pharma at the JonesHealthcare Seaside Summit?

David R. Parkinson, President and CEO of ESSA Pharma, will represent the company at the JonesHealthcare Seaside Summit.

What is the focus of ESSA Pharma's presentation at the JonesHealthcare Seaside Summit?

The presentation will focus on ESSA Pharma's novel therapies for the treatment of prostate cancer.

How can I access the live webcast of ESSA Pharma's presentation at the JonesHealthcare Seaside Summit?

The live webcast will be accessible in the Investors/Events & Presentations section of ESSA Pharma's website.

Will the panel discussion 'Innovations and Challenges in Prostate Cancer' be webcast?

No, the panel discussion 'Innovations and Challenges in Prostate Cancer' will not be webcast.

For how long will the webcast of ESSA Pharma's presentation be available?

The webcast will be archived on ESSA Pharma's website for 90 days following the event.